Effect of COVID-19 during pregnancy: Studying the maternal and neonatal outcomes and assessing the placental changes related to SARS-CoV-2
Madan, S.; Ramar, D.; Patel, D.; Shah, N.; Shah, B.; Thakkar, V.; Shah, H.; Chovatia, R.; Dabhi, P.; Patel, M.; Patel, A.; Bapat, N.; Bhatt, P.; Naik, A.; Rana, M.; Nayak, H.; Sharma, K. D.; Parikh, P.; Mehta, B.
Show abstract
BackgroundPregnant females affected with COVID-19 are reported to have poorer disease outcomes as compared to non-pregnant females of a similar age group. COVID-19 may lead to adverse changes in the placenta, which needs to be studied. MethodsThis is a case series of 63 pregnant women hospitalized with COVID-19 from May 2020 to February 2021.The primary outcomes were maternal death or complications. Results63 women were studied. 83.3% of women were in the age group of 26 to 35 years. 33% women had associated comorbidities. 68.3% of women tested positive in their third trimester, 15.9% and 11% tested positive in their second and first trimesters respectively. 73% women had mild disease and 27% women required oxygen support. 3/63 women died. One woman in the second and two women in the third trimester died respectively. Histopathological examination in 13 placentae (of 19 placentae examined) were suggestive of maternal and fetal malperfusion. ConclusionPregnant COVID-19 women may develop disease-related as well as obstetric complications.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.